Drug intelligence / Profile preview

estetrol

Development stage
Phase 4
Lead developer
Mithra Pharmaceuticals
Modality
Small Molecules
Administration
Oral
01

Overview

Estetrol is a synthetic estrogen and a naturally occurring steroid hormone produced only during pregnancy by the fetal liver. It is used primarily in combination with drospirenone as an oral contraceptive to prevent pregnancy. Estetrol acts as an agonist of estrogen receptors (ERα and ERβ), with moderate affinity and selectivity for ERα over ERβ. Its mechanism involves suppression of ovulation through modulation of the hypothalamic-pituitary-gonadal axis. Compared to other estrogens like ethinylestradiol or estradiol, estetrol has lower receptor affinity but higher metabolic stability and favorable pharmacokinetics. It demonstrates high selectivity for estrogen receptors with minimal off-target activity on other steroid hormone receptors or cytochrome P450 enzymes[1][4]. The drug was developed by Mithra Pharmaceuticals and approved in combination products such as Nextstellis (with drospirenone) for contraception[1][3].

Brand names
DrovelisLydisilkaNextstellis
Other names
15α-hydroxyestriolEstétrolEstetrolumOestetrol
02

Targets

ESR2 (ERβ)ESR1 (ERα)

Beyond the preview

Go deeper on estetrol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on estetrol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call